Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Symphony IL-6 Study in Patients at Risk of Severe Sepsis Due to COVID-19 and/or Influenza Infection

NCT05665153 is registered in ClinicalTrials.gov with Bluejay Diagnostics, Inc. as lead sponsor.

NCT NCT05665153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05665153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Symphony IL-6 Study in Patients at Risk of Severe Sepsis Due to COVID-19 and/or Influenza Infection
Lead sponsor
Bluejay Diagnostics, Inc.
Phase
Observational
Overall status
Unknown status
Start date
November 22, 2022
Completion date
November 21, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe sepsis